Lek Takeover: Novartis Publishes Takeover Bid
Ljubljana, 28 September - Novartis subsidiary Servipharm has published a public takeover bid for Ljubljana-based drug-maker Lek in Saturday's edition of the daily Delo. The Swiss pharmaceutical group offers Lek shareholders SIT 95,000 (EUR 416.21) per share, which they can be paid in domestic currency or euros. Novartis aims to obtain 51 percent of Lek by 28 October.
The rest of this news item is available to subscribers.
The news item consists of 1.350 characters (without spaces) or 258 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.